宏源药业前三季度净利亏损110.02万元

Core Insights - Hongyuan Pharmaceutical (301246) reported a slight decline in revenue for the first three quarters of 2025, with total revenue approximately 1.317 billion yuan, a year-on-year decrease of 0.39% [1] - The company experienced a significant drop in net profit attributable to shareholders, amounting to approximately -1.1002 million yuan, a year-on-year decrease of 103.04% [1] - In contrast, the third quarter showed positive growth, with revenue around 435 million yuan, reflecting a year-on-year increase of 2.45% [1] - The net profit for the third quarter was approximately 4.7103 million yuan, marking a substantial year-on-year increase of 1316.05% [1]